Post

Health Canada approves third stage of ProJenX’s ALS trial

US-based clinical-stage biotech ProJenX has been given authorisation by Health Canada to launch the final part of its Phase I …

New study challenges current age-based colorectal cancer screening guidelines

Colorectal cancer (CRC) is responsible for more than 50,000 deaths per year and is the third most fatal type of …

Candel downsizes to focus on oncolytic virus-based cancer therapies

Candel Therapeutics has fired approximately 50% of its workforce in an effort to extend its cash runway into Q4 FY …

CTO Europe 2023: Reflections on drug development through the phases

Precision medicine oncology trial designs improve the likelihood of a drug’s approval by 38%, based on a presentation held by …

How to manage temperature-controlled shipments in unpredictable climate zones

Drugs have very specific temperature and storage requirements that must be considered at every point in the supply chain. Temperatures …